3/27
11:27 am
cv
CapsoVision (CV) had its price target lowered by Benchmark Co. from $14.00 to $10.00. They now have a "speculative buy" rating on the stock.
Medium
Report
CapsoVision (CV) had its price target lowered by Benchmark Co. from $14.00 to $10.00. They now have a "speculative buy" rating on the stock.
3/26
05:56 pm
cv
CapsoVision Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
CapsoVision Q4 Earnings Call Highlights [Yahoo! Finance]
3/26
04:27 pm
cv
CapsoVision, Inc. reports Q4 results [Seeking Alpha]
Low
Report
CapsoVision, Inc. reports Q4 results [Seeking Alpha]
3/26
04:05 pm
cv
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
3/23
09:14 pm
cv
CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening [Yahoo! Finance]
Medium
Report
CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening [Yahoo! Finance]
3/20
08:29 am
cv
CapsoVision Announces $14 Million Private Placement Financing [Yahoo! Finance]
Low
Report
CapsoVision Announces $14 Million Private Placement Financing [Yahoo! Finance]
3/20
08:00 am
cv
CapsoVision Announces $14 Million Private Placement Financing
Medium
Report
CapsoVision Announces $14 Million Private Placement Financing
3/12
04:14 pm
cv
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026 [Yahoo! Finance]
Low
Report
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026 [Yahoo! Finance]
3/12
04:05 pm
cv
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026
Low
Report
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026
3/9
04:05 pm
cv
CapsoVision to Participate in the 38th Annual ROTH Conference
Low
Report
CapsoVision to Participate in the 38th Annual ROTH Conference
1/10
01:07 am
cv
Medium
Report
12/31
08:05 am
cv
CapsoVision (NASDAQ:CV) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
High
Report
CapsoVision (NASDAQ:CV) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
12/29
08:21 pm
cv
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus® [Yahoo! Finance]
Medium
Report
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus® [Yahoo! Finance]
12/29
04:05 pm
cv
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus®
Medium
Report
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus®